The purpose of this study was to identify speech-language pathologists' (SLP) preferences for the texture and order of bolus trials administered to neurogenic patients during both clinical-bedside evaluation and videofluoroscopic swallow study. Since specific preferences have not been determined for bolus administration in the neurogenic population, this study sought to provide information on current clinical practice and judgment. A non-experimental, cross-sectional study was conducted through a Qualtrics survey sent via email to members of the New Jersey Speech-Language-Hearing Association. Results indicate a significant variation among the 15 SLP participants in terms of bolus trial administration and protocol. Survey responses also indicate that clinical judgment of SLPs supersedes protocol recommendations.